Dividend Investing Center
Portfolio Strategy Center
ETFs & Funds
This user currently has no profile.
Independent biotech equities investor. Retired at 33 from a bay area investment firm.
Commodities, Developed International Markets, ETFs, Options, Stocks - long, Stocks - short
Currently, there is no company profile for novapharma.
Currently, there are no blog details for novapharma.
Currently, there are no book details for novapharma.
This conference call is BRU...
8Point3: An Attractive Investment For Yield Inv...
Takeda just bailed on them ...
Intra-Cellular Therapies Just Might Have Found ...
Pet food isn't sexy, but pe...
Blue Buffalo's Heavy SG&A Spending Means The St...
I typically agree with the ...
Trevena's GPCR Biased Ligand Technology Could B...
Will be watching it Monday ...
Update: Cynk Technology - Sensing Trouble, The ...